Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the effect of tranexamic acid (on blood loss and transfusion requirements in patients with proximal humeral fractures requiring open surgical approaches. This a blinded, controlled, therapeutic trial in which the patients will be randomized to receive TXA or no drug intervention. The primary outcome is the estimated total blood loss. This study presents only minimal risks for the included patients.


Clinical Trial Description

Studies have shown that hip fractures have a significant perioperative blood loss. Postoperative anaemia is associated with a higher morbidity and mortality. Tranexamic acid is a safe and effective antifibrinolytic widely used to reduce blood loss in other forms of orthopaedic surgery and in traumatized patients. However, evidence on the effectiveness of TXA in shoulder fractures is more limited. Proximal humeral fractures represent a common orthopedic injury in elderly patients The goal of this study is to assess if the use of topic tranexamic acid in patients with proximal humeral fractures will result in a reduction in blood losses and blood transfusion rates. The hypothesis is that by providing topic TXA at the end of surgery will decrease the amount of preoperative and intraoperative bleeding thereby leading to a decreased need for postoperative transfusion. This a blinded, controlled, therapeutic trial in which the patients will be randomized to receive TXA or no drug intervention. The primary outcome is the estimated total blood loss. Secondary outcomes, need for blood transfusion, length of stay, and rate of thromboembolic events. Candidates for the study will be consecutive patients with a diagnosis of proximal humeral fracture. All patients meeting inclusion criteria will be recruited for enrollment into the study. Informed consent will be obtained from the patient prior to randomization. At that time, each patient will be randomized into one of two groups by an independent staff using computer generated randomization and allocation concealment. The two patient groups will include: 1. Study group: 2 g of tranexamic acid topically infused in shoulder joint before surgical closure. 2. Control group: no intervention Both patient groups will be blinded with regard to drug intervention. Patients will be treated surgically with internal fixation or arthroplasty. Blood transfusion criteria will remain consistent with hospital standards (Hb<7 g/dL or >9 g/dL if symptomatic anemia). Total number of blood transfusions received will be documented upon patient discharge. Deep vein thrombosis (DVT) prophylaxis will remain consistent with hospital standards (subcutaneous heparin from admission until 12 hours prior to surgery and beginning 6 hours after surgery). Patients will be followed 30 days. Diagnostic studies to assess for thromboembolic events (i.e. DVT, pulmonary embolism (PE), and stroke) will be ordered only if the patient develops clinical signs or symptoms that justify their use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05437822
Study type Interventional
Source Elda University Hospital
Contact Alejandro Lizaur-Utrilla, MD
Phone +34 966989019
Email lizaur1@telefonica.net
Status Recruiting
Phase Phase 4
Start date June 29, 2022
Completion date June 24, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06467006 - AI PREDICTION FOR PROXIMAL HUMERAL FRACTURES
Active, not recruiting NCT06444828 - Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements N/A
Recruiting NCT04762667 - Individual Preoperative Planning for RSA N/A
Active, not recruiting NCT03531463 - The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly N/A
Terminated NCT03711591 - Single Center Post Approval Proximal Humerus Fixation With the Conventus Cage PHâ„¢ Device
Completed NCT03339570 - Orthopaedic Treatment Proximal Humeral Fractures
Completed NCT03919422 - Paravertebral Block for Proximal Humeral Fracture Surgery N/A
Completed NCT01984112 - Proximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts N/A
Completed NCT00863473 - Comminuted Proximal Humeral Fractures. A Randomised Study of Surgical Versus Conservative Treatment Phase 2
Not yet recruiting NCT06416618 - Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years N/A
Recruiting NCT04543682 - A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture Phase 1/Phase 2
Completed NCT05215613 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Plates and Screws System
Recruiting NCT04748016 - 3D-printed Bone Models in Addition to CT Imaging for Intra-articular Fracture Repair N/A
Completed NCT04786639 - Surgical Fixation and Non-Operative Management Outcomes in Proximal Humerus Fractures
Active, not recruiting NCT04623346 - Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic
Terminated NCT03567954 - The Accuracy of Ultrasound in Detecting Rotator Cuff Tears in Proximal Humerus Fracture Patients
Recruiting NCT03626038 - Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System N/A
Not yet recruiting NCT05960435 - Proprioceptive Neuromuscular Facilitation Techniques in Proximal Humerus Fractures N/A
Recruiting NCT03243409 - Perioperative Complications in Reversed Shoulder Arthroplasties N/A
Completed NCT04622852 - Pegs for Osteofixation of Proximal Humeral Fractures